These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12387064)

  • 1. [Regenerative medicine in diabetes by beta cell therapy and promotion of beta cell growth and differentiation].
    Miyagawa J
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():643-9. PubMed ID: 12387064
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging therapies: controlling glucose homeostasis, immunotherapy, islet transplantation, gene therapy, and islet cell neogenesis and regeneration.
    Ruggles JA; Kelemen D; Baron A
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):239-52, xii. PubMed ID: 15053905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Islet transplantation, stem cell transfer and regenerative therapy in diabetes mellitus].
    Bretzel RG; Eckhard M; Jahr H; Brendel MD
    Dtsch Med Wochenschr; 2006 Apr; 131(16):903-6. PubMed ID: 16625486
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.
    List JF; Habener JF
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E875-81. PubMed ID: 15140754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New sources of pancreatic beta-cells.
    Bonner-Weir S; Weir GC
    Nat Biotechnol; 2005 Jul; 23(7):857-61. PubMed ID: 16003374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
    Wang Q; Brubaker PL
    Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucagon-like peptide-1(GLP-1)].
    Wasada T
    Nihon Rinsho; 2004 Jun; 62(6):1175-80. PubMed ID: 15206160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes.
    Knudsen LB
    J Med Chem; 2004 Aug; 47(17):4128-34. PubMed ID: 15293981
    [No Abstract]   [Full Text] [Related]  

  • 9. [Future therapeutic options and their indications: transplantation and the possibilities of regenerative therapy for diabetes type 1].
    Seissler J
    MMW Fortschr Med; 2008 Oct; 150(44):50-1. PubMed ID: 19024493
    [No Abstract]   [Full Text] [Related]  

  • 10. Routes to regenerating islet cells: stem cells and other biological therapies for type 1 diabetes.
    Kodama S; Faustman DL
    Pediatr Diabetes; 2004; 5 Suppl 2():38-44. PubMed ID: 15601373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progenitor cells in the adult pancreas.
    Holland AM; Góñez LJ; Harrison LC
    Diabetes Metab Res Rev; 2004; 20(1):13-27. PubMed ID: 14737742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In search of endocrine progenitor/stem cells in the human pancreas.
    Hayek A
    Pediatr Diabetes; 2004; 5 Suppl 2():70-4. PubMed ID: 15601376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of diabetes mellitus. New developments and hopes].
    Verspohl EJ
    Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth of insulin-producing beta cells. Perhaps a new way to treat type 1 diabetes].
    Annerén C
    Lakartidningen; 2002 May; 99(21):2394-5, 2398-9. PubMed ID: 12090167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells in the treatment of diabetes.
    Otonkoski T; Gao R; Lundin K
    Ann Med; 2005; 37(7):513-20. PubMed ID: 16278164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.
    Holst JJ; Toft-Nielsen MB; Orskov C; Nauck M; Willms B
    Ann N Y Acad Sci; 1996 Dec; 805():729-36. PubMed ID: 8993469
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.
    Ramiya VK; Maraist M; Arfors KE; Schatz DA; Peck AB; Cornelius JG
    Nat Med; 2000 Mar; 6(3):278-82. PubMed ID: 10700229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of glucagon-like peptide 1 in diabetes.
    Meier JJ; Nauck MA
    Curr Opin Investig Drugs; 2004 Apr; 5(4):402-10. PubMed ID: 15134281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow and pancreatic islets: an old story with new perspectives.
    Ciceri F; Piemonti L
    Cell Transplant; 2010; 19(12):1511-22. PubMed ID: 20719074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do stem cell-derived islets represent a commercially viable treatment for Type 1 and 2 diabetes?
    Wong AL; Nierras CR
    Regen Med; 2010 Nov; 5(6):839-42. PubMed ID: 21082882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.